Lyceum Pharmaceuticals, Inc. combines unique genomic intellectual property with a novel R&D strategy to develop qualitatively superior pharmaceuticals. Lyceum’s technology grows out of research from University of California, Irvine Professor Michael R. Rose. Lyceum combines three key tools: 1. Selection: which is used to produce model populations with extreme functions or disorders; 2. Genomics: which is used to identify all the molecular genetic changes which underlie such disorders or functions; 3. Functional physiology: which is used to determine the biological mechanisms that connect the genome to particular functions or disorders. Our unique evolutionary genomic approach places Lyceum in the position to find the next generation of pharmaceuticals.